Equate 2% Salicylic Acid Acne Treatment Pad

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of this product. The product should be applied by wiping a pad over the face and neck, ensuring that the entire affected area is covered with a thin layer.

Initial dosing should consist of one application daily to minimize the risk of excessive drying of the skin. Based on the patient's response and as directed by a physician, the frequency of application may be gradually increased to two or three times daily.

In cases where bothersome dryness or peeling occurs, it is advisable to reduce the frequency of application to once daily or every other day to alleviate these symptoms.

Contraindications

Use of this product is contraindicated in the following situations:

• The product should be kept out of reach of children to prevent accidental ingestion or misuse.

• If skin or eye irritation develops, discontinue use and consult a healthcare professional.

• Contact with the eyes must be avoided; in the event of contact, rinse thoroughly with water.

• Concurrent use with other topical acne medications may increase the risk of skin irritation and dryness; therefore, only one topical acne medication should be used at a time.

• The product is intended for use on the face and neck only; application to other areas is not recommended.

Warnings and Precautions

For external use only. It is imperative that this product is not ingested.

General precautions should be observed to ensure safety. This product must be kept out of reach of children to prevent accidental ingestion. In the event of swallowing, immediate medical assistance should be sought by contacting a healthcare professional or the Poison Control Center at 1-800-222-1222.

Healthcare professionals should advise patients to discontinue use and consult a physician if any skin or eye irritation occurs. Prompt medical attention is essential in such cases to prevent further complications.

In case of ingestion, it is critical to obtain emergency medical help or contact the Poison Control Center at 1-800-222-1222 without delay.

Side Effects

Patients should be aware that the product is intended for external use only. In clinical practice, it is important to monitor for any adverse reactions that may arise during use.

In the event of skin or eye irritation, patients are advised to discontinue use immediately and consult a healthcare professional. This precaution is essential to ensure the safety and well-being of individuals using the product.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Equate 2% Salicylic Acid Acne Treatment Pad (2% salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep the medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center (1-800-222-1222) should be contacted.

For topical application, it is recommended to initiate treatment with one application daily to minimize the risk of excessive skin drying. Dosage may be gradually increased to two or three times daily as needed or as directed by a healthcare professional. Should patients experience bothersome dryness or peeling, the frequency of application should be reduced to once daily or every other day.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The safety of this product during pregnancy has not been established. The use of salicylic acid is generally contraindicated in pregnancy due to potential risks to the fetus, including the possibility of teratogenic effects. Pregnant women are advised to consult a healthcare provider before using this product to discuss potential risks and benefits.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

There is currently no specific information available regarding overdosage for this medication. In the absence of documented overdosage data, healthcare professionals are advised to exercise caution and monitor patients closely for any unusual symptoms or adverse effects that may arise following administration.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Continuous monitoring of vital signs and clinical status is essential to ensure patient safety.

Healthcare professionals should also consider consulting a poison control center or relevant toxicology resources for guidance on management strategies tailored to the specific circumstances of the overdosage event.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

Reports of side effects have been received through voluntary submissions and surveillance programs. Healthcare professionals and patients are encouraged to report any adverse events to the designated contact number provided for this purpose.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children. Instruct patients that if the product is swallowed, they should seek medical help or contact the Poison Control Center at 1-800-222-1222 immediately.

Patients should be informed to stop using the product and consult a doctor if they experience any skin or eye irritation. It is important to emphasize the need to avoid contact with the eyes; if the product does get into the eyes, patients should rinse thoroughly with water.

Providers should also discuss the potential for skin irritation and dryness, particularly if patients are using another topical acne medication concurrently. Patients should be advised to use only one topical acne medication at a time to minimize the risk of irritation.

Finally, healthcare providers should recommend that patients limit the use of the product to the face and neck to ensure safe and effective application.

Storage and Handling

The product is supplied in a jar, which must be kept tightly closed to maintain its integrity. It is essential to store the jar in a cool, dry place to ensure optimal conditions. Freezing the product is not recommended, as it may compromise its quality. Additionally, it is important to note that the product should not be flushed down the toilet.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Equate 2% Salicylic Acid Acne Treatment Pad, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)